- Home
- CCEL vs INLX Comparison
CCEL vs INLX Comparison
Compare CCEL & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- INLX
- Stock Information
- Founded
- CCEL 1989
- INLX 1996
- Country
- CCEL United States
- INLX United States
- Employees
- CCEL N/A
- INLX N/A
- Industry
- CCEL Managed Health Care
- INLX EDP Services
- Sector
- CCEL Health Care
- INLX Technology
- Exchange
- CCEL Nasdaq
- INLX Nasdaq
- Market Cap
- CCEL 34.8M
- INLX 40.8M
- IPO Year
- CCEL 1997
- INLX N/A
- Fundamental
- Price
- CCEL $4.55
- INLX $11.10
- Analyst Decision
- CCEL Strong Buy
- INLX
- Analyst Count
- CCEL 1
- INLX 0
- Target Price
- CCEL $8.50
- INLX N/A
- AVG Volume (30 Days)
- CCEL 10.6K
- INLX 6.8K
- Earning Date
- CCEL 10-15-2025
- INLX 11-12-2025
- Dividend Yield
- CCEL 13.19%
- INLX N/A
- EPS Growth
- CCEL N/A
- INLX N/A
- EPS
- CCEL N/A
- INLX N/A
- Revenue
- CCEL $31,747,500.00
- INLX $17,127,854.00
- Revenue This Year
- CCEL $1.75
- INLX N/A
- Revenue Next Year
- CCEL N/A
- INLX $14.19
- P/E Ratio
- CCEL N/A
- INLX N/A
- Revenue Growth
- CCEL N/A
- INLX N/A
- 52 Week Low
- CCEL $4.09
- INLX $8.74
- 52 Week High
- CCEL $9.43
- INLX $16.50
- Technical
- Relative Strength Index (RSI)
- CCEL 47.89
- INLX 45.83
- Support Level
- CCEL $4.35
- INLX $11.00
- Resistance Level
- CCEL $4.60
- INLX $11.10
- Average True Range (ATR)
- CCEL 0.13
- INLX 0.20
- MACD
- CCEL -0.00
- INLX -0.04
- Stochastic Oscillator
- CCEL 54.26
- INLX 35.21
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.